These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study. Ceballos KM, Nielsen GP, Selig MK, O'Connell JX. Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549 [Abstract] [Full Text] [Related]
9. Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas. An immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies. Seidal T, Kindblom LG, Angervall L. Appl Pathol; 1987 Nov; 5(4):201-19. PubMed ID: 3689591 [Abstract] [Full Text] [Related]
10. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma. Miettinen M. Arch Pathol Lab Med; 1988 Jun; 112(6):637-40. PubMed ID: 2454091 [Abstract] [Full Text] [Related]
15. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Perez-Montiel MD, Plaza JA, Dominguez-Malagon H, Suster S. Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070 [Abstract] [Full Text] [Related]
16. Ossifying fibromyxoid tumor: modified myoepithelial cell tumor? Report of three cases with immunohistochemical and electron microscopic studies. Min KW, Seo IS, Pitha J. Ultrastruct Pathol; 2005 Apr; 29(6):535-48. PubMed ID: 16316954 [Abstract] [Full Text] [Related]
17. Leiomyosarcomas: three cases with desmin positive tumour cells, lacking ultrastructural features of smooth muscle cells. Roholl PJ, de Jong AS, Albus-Lutter CE, van Unnik JA. Histol Histopathol; 1988 Oct; 3(4):389-94. PubMed ID: 2980248 [Abstract] [Full Text] [Related]